/GENPF

GENPF Stock - Genix Pharmaceuticals Corporation

Q: What is the analyst price target for GENPF?

Analyst price target information is not currently available for GENPF.

Q: What is GENPF's market cap?

Market capitalization information is not currently available for GENPF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.03+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.03

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GENPF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.39

52W High$0.04

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$4,051	$12,347	N/A	N/A	N/A
Gross Profit	$1,297	$3,263	$-564,173	$-536,611	$-361,567
Gross Margin	32.0%	26.4%	N/A	N/A	N/A
Operating Income	$-241,003	$-880,894	$-1,031,068	$-1,653,479	$-715,669
Net Income	$-73,196	$-4,395,574	$-1,073,998	$-1,652,516	$-718,663
Net Margin	-1806.9%	-35600.3%	N/A	N/A	N/A
EPS	$-0.00	$-0.07	$-0.02	$-0.03	$-0.01

Company Overview

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

Visit Website

Frequently Asked Questions about GENPF

What is GENPF's current stock price?

Genix Pharmaceuticals Corporation (GENPF) is currently trading at $0.03 per share. The stock has moved +0.00% today.

What is the analyst price target for GENPF?

No analyst price targets are currently available for this stock.

What sector is Genix Pharmaceuticals Corporation in?

Genix Pharmaceuticals Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GENPF's market cap?

Genix Pharmaceuticals Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does GENPF pay dividends?

No, Genix Pharmaceuticals Corporation does not currently pay a dividend to shareholders.